Several buyout firms including Advent International, Baring Private Equity Asia, Bain Capital, Blackstone, Carlyle and KKR have been approached to buy Fosun-owned Gland Pharma. If the deal goes forward, it will be India's biggest pharma deal, a report by the Economic Times (ET) said. Currently, Fosun owns a 57.86 per cent stake in the Indian generic injectable maker Gland Pharma.
Fosun acquired Gland Pharma in 2017 for $1.1 billion. It was listed in 2020 in a Rs 6,480 crore IPO. Fosun has appointed Morgan Stanley to find the buyer for the firm.
In the discussions, the significant control premium sought